The effectiveness of nitrofurantoin in suppressing bacterial growth in the urinary tract was evaluated by using two different experimental models. Pyelonephritis was produced in rats by direct inoculation of 104 Escherichia coil in the medulla of left kidney. Ascending urinary tract infection was induced by inoculation into the urinary bladder of 107 Proteus mirabilis, after a partial cystectomy. Nitrofurantoin was shown to be effective in suppressing bladder bacteriuria, in preventing ascending pyelonephritis, and also in preventing bacterial multiplication in kidney tissue following direct inoculation.
The effectiveness of nitrofurantoin in suppressing bacterial growth in the urinary tract was evaluated by using two different experimental models. Pyelonephritis was produced in rats by direct inoculation of 104 Escherichia coil in the medulla of left kidney. Ascending urinary tract infection was induced by inoculation into the urinary bladder of 107 Proteus mirabilis, after a partial cystectomy. Nitrofurantoin was shown to be effective in suppressing bladder bacteriuria, in preventing ascending pyelonephritis, and also in preventing bacterial multiplication in kidney tissue following direct inoculation.
Recent experimental observations (2, 4) indicate that after administration of nitrofurantoin the drug is probably present in the interstitium of the renal medulla in concentrations higher than those required to suppress multiplication of common urinary pathogens. These findings certainly suggest that nitrofurantoin may have a direct effect against kidney parenchymal infection, besides its known effectiveness in suppressing multiplication of susceptible organisms in the urinary bladder (3) .
The experimental studies reported herein were performed in an attempt to further investigate the site of action of nitrofurantoin in urinary tract infection.
MATERIAL AND METHODS Aninals. Sprague Dawley rats, weighing 200 to 300 g were used.
Bacteria. A strain of Escherichia coli and a strain of Proteus mirabilis recovered from urine of patients with urinary tract infection were employed. Stock cultures were maintained by storing portions of an 18-hr culture in Trypticase Soy Broth (BBL) at -20 C. Inocula were prepared by subculturing a sample of the stock culture in Trypticase Soy Broth at 37 C for 4 hr.
Production and treatment of renal parnchymal infection. For direct injection of bacteria into the renal medulla, a midline abdominal incision was made, and, after exposure of the left kidney, 0.1 ml of a 1:1,000 dilution of the culture in saline was injected through a 25-gauge needle. The incision was then closed with 000 silk.
Animals were treated with an aqueous solution of nitrofurantoin, in doses of 25, 50, and 100 mg per kg of body weight, divided into two intramuscular (im) injections daily. Therapy was initiated within 1 day and on the third day after the intramedullary injection of bacteria, and was carried out for three days. Control animals were treated with saline solution given in a similar way. All animals were sacrificed 48 hr after cessation of therapy.
Production and treatment of bladder infection. For bladder injections, a small suprapubic midline incision was made, and a 25-gauge needle was inserted through the wall of the urinary bladder after completion of a partial cystectomy (removal of over half of the bladder). Details of this partial cystectomy have been described elsewhere (5) . Of a 1 :10 dilution in saline of the bacterial culture, 0.1 ml was then injected. The incision was closed with 000 silk.
Therapy was conducted with an aqueous solution of nitrofurantoin starting either within 30 min or 7 days after the bacterial inoculation. The dose used was 25 mg per kg of body weight divided into two doses given im daily for a period of 1 week. Control animals were treated with saline solution given in a similar way. All animals were killed at 48 hr after completion of therapy.
Bacterial enumeration. After death, urine was collected with a 25-gauge needle from the exposed bladder. Both kidneys were removed and homogenized separately in 1:10 dilutions in distilled water. Urine and tissue homogenates were serially diluted in saline solution, and 1 ml of each dilution was plated in Trypticase Soy Agar pour plates and incubated at 37 C for 48 hr to permit enumeration of the organisms present. The number of bacteria inoculated in the animals was also determined by the same technique.
Criteria for diagnosis of urinary tract infection. Urinary tract infection was always considered when there were 100,000 or more organisms per g of kidney tissue or per ml of urine. In the experiments in which bacteria were injected in the renal medulla or urinary bladder, the presence of more organisms per gram of kidney tissue or millimeter of urine than the total amount injected (10,000 organisms) was also interpreted as indi- (67.9%) of the treated group (P < 0.05). Therapy protected the right kidney of those animals from bacterial invasion. In fact, practically no bacteria was found in the right kidney in 52 of 66 treated rats as compared with 10 of 31 (32.2%) controls (P < 0.01; Table 2 ). Similar suppression of bacterial growth was also demonstrated in the bladder urine (Table 3) . Less than 10,000 organisms were found in only 10 of 31 controls (32.2%) as compared to 50 of 59 (84.7%) of the treated group (P < 0.01).
Effect of nitrofurantoin after bladder inoculation of bacteria. Therapy starting within 30 min after bacterial inoculation into the urinary bladder resulted in only 5 infected out of 18 animals, as compared to 11 out of 12 of the control group (Table 4) . When therapy was delayed (started 7 days after bacterial inoculation), there were 9 animals infected out of 14, as compared to 10 of 12 controls (Table 5) .
DISCUSSION
With the experimental models used, nitrofurantoin did show an effect in suppressing bacterial growth in the kidney after direct inoculation of bacteria into the renal medulla. There were less abscesses in the kidneys of the treated group, and, in a significantly higher number of treated a Therapy was started within 30 min after bacterial inoculation in the bladder cavity. Nitrofurantoin was used in a dose of 25 mg/kg, and therapy was conducted for 7 days. ACTION OF NITROFURANTOIN animals, there was no multiplication of the original bacterial inoculum. These findings suggest that nitrofurantoin was directly interfering with the development of kidney tissue infection. This is not surprising taking into account previous experimental data indicating a probable concentration of this drug in the renal medulla.
Even though nitrofurantoin does not produce effective blood levels after therapeutic doses (7), the assumption that this drug posesses antibacterial activity in kidney tissue could be based on the following observations. (i) Stop-flow data indicate that this agent is reabsorbed in the distal tubule and possibly in the adjacent portion of the proximal tubule (1) . (ii) Lymph concentrations of nitrofurantoin draining the medulla are higher than cortical lymph levels, and they are much above the inhibitory concentration of several pathogens of the urinary tract (4) . (iii) It is possible to demonstrate, by autoradiographic technique, localization of nitrofurantoin not only within medullary tubular lumen but also in interstitial spaces, in concentrations thought to be above the minimal inhibitory concentration for many urinary pathogens (2) . It seems quite obvious that a high concentration of an antibacterial drug in the interstitium of the renal medulla would probably be of great therapeutic importance because kidney infection usually starts in this area, and also because infection in the medulla probably serves to maintain the septic process.
Nitrofurantoin was even more effective in suppressing bacterial growth in the urinary bladder of infected rats. In fact, there was definite protection of the right kidney in treated animals previously subjected to direct inoculation of E. coll in the left renal medulla. This observation showed a straight correlation between the protection of the right kidney and the suppression of bacterial growth in the urinary bladder (Tables 2 and 3) . Also, ascending kidney infection was less frequent in the treated group after the inoculation of P. mirabilis into the urinary bladder. In fact, whereas infection was observed in almost all control animals, therapy with nitrofurantoin greatly reduced the finding of kidney and bladder infection in rats subjected to the bladder inoculation of P. mirabilis (Tables 4 and 5 ). Those findings are in agreement with the fact that nitrofurantoin is readily filtered through the glomeruli and also secreted by the proximal tubule (5, 6) , appearing in high concentration in the urine.
With the results obtained after intrabladder inoculation, it was not possible to demonstrate conclusively that the sooner therapy was started the better were the results. This was in contrast to previous observations of Van Ryzin et al. (6) who showed that nitrofurantoin reduced severity of experimental renal lesions when treatment was begun 6 hr after intrabladder inoculation, but was ineffective when treatment was begun after 2 days. However, those were long-term studies with a different experimental model.
